LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced data finding that treating people living with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD) with semaglutide significantly improved a variety of biomarkers of cardiovascular risk. These results from the SLIM LIVER […]